Levocetirizine dihydrochloride
- Level
- Commodity
- Parent
- 51313100
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51313120This classification denotes a histamine-1 receptor antagonist, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier SOD6A38AGA. European Medicines Agency schedules Levocetirizine dihydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB20474. Levocetirizine dihydrochloride generally arises in the molecular formula C21H25CLN2O3.2CLH. The term 'levocetirizine dihydrochloride' is a United States Adopted Name designation. Most nations, for tariff and trade purposes, schedule levocetirizine dihydrochloride under HS 29335995 and SITC 51576. As of Q4 2014, LEVOCETIRIZINE DIHYDROCHLORIDE remains US FDA's Preferred Term for this commodity. Levocetirizine dihydrochloride bears US NLM identifiers UMLS ID C1311681 and NCI Concept Code C72814. SMILES: C1CCC(CC1)[C@H](C2CCC(CC2)CL)N3CCN(CC3)CCOCC(=O)O.CL.CL.
Same parent
Under 51313100 · 20Activities that produce or sell this
KBLI · 9Inherited from family 51310000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.